ÐÂÎÅÖÐÐÄ
½èÖú¿Õ¼ä¶à×éѧ¼¼ÊõÑо¿Ë¼Â·¶Ô¾ÞÊÉϸ°û½øÐÐÑо¿£¬ÊÇÄ¿½ñÈȵãµÄÇ°ÑØÆ«ÏòÖ®Ò»¡£ÒòΪÂÑ°×ÖÊÊÇϸ°û¹¦Ð§µÄ×îÖÕµ£¸ºÕߣ¬ÈçºÎ½âÎöÂÑ°×ÖÊ×éѧµÄʱ¿ÕÌØÒìÐÔ£¬ÊÇÁ˽⼲²¡±¬·¢Éú³¤¡¢×éÖ¯ÔλµÄ΢Çé¿öÒìÖÊÐÔµÄÒªº¦ÒòËØ¡£ Tissue Cytometry¼¼Êõ×÷Ϊ¿Õ¼ä×éѧÑо¿ÌåϵµÄÒ»Ô±£¬ÔÚ¿Õ¼ä¶à×éѧÆÊÎöÖÐÕ¹ÏÖ³öÁËÆäÆæÌصÄÓÅÊÆ¡£ ¿Õ¼ä¶à×éѧÑо¿ÖÐÊ×ÏÈÒªÔλ¿Õ¼äÐÅÏ¢µÄÍêÕû¿É¿¿£¬Tissue Cytometry¼¼Êõ¼æÈÝͨÀý×éÖ¯ÇÐƬ£¬Ê×ÏÈÈ·±£ÁË×éÖ¯½á¹¹µÄÍêÕûÐÔ£¬Ê¹µÃÑо¿ÈËÔ±Äܹ»ÔÚ½Ó½ü×ÔȻ״̬ÏÂÊÓ²ìϸ°û¼äµÄÏ໥×÷ÓᣠÆä´Î£¬Tissue Cytometry¼¼Êõͨ¹ý¾µäµÄÏÔ΢³ÉÏñ¹â·ºÍ¶¨Î»ÅÄÉã»ñµÃÁ˸ßÇø·ÖÂʳÉÏñÄÜÁ¦£¬ÎªÊ¶±ðºÍÁ¿»¯²î±ð×éÖ¯ÖоÖÊÆϸ°ûÒìÖÊÐÔÌṩÁË¿ÉÄÜ£»½áºÏÈí¼þµÄÇ¿´óÆÊÎö¹¦Ð§£¬Ñо¿ÈËÔ±Äܹ»¶Ô´ó¹æÄ£µÄͼÏñÊý¾Ý½øÐпìËÙ׼ȷµÄ´¦Àí£¬´Ó¶øÔÚ·Ö×ÓˮƽÉϽÒʾ΢Çé¿öµÄÅÓ´óÐÔ¡£ÕâÖÖ¼¼ÊõµÄÓ¦Óò»µ«¼ÓËÙÁ˶ԾÞÊÉϸ°ûµÄÑо¿Àí½â£¬Ò²Îª¿ª·¢ÐµÄÖÎÁÆÕ½ÂÔÌṩÁËÖØÒªµÄÐÅÏ¢¡£ ½¾ü¾üÒ½´óѧµÚÒ»Á¥ÊôÒ½Ôº£¨ÖØÇìÎ÷ÄÏÒ½Ôº£©È«¾üÁÙ´²²¡ÀíѧÑо¿Ëù±åÐÞÎäԺʿ¡¢Ê±Ó긱½ÌÊÚ¡¢Æ½éó·¼½ÌÊÚÍŶÓÁªºÏ½¾ü¾üÒ½´óѧµÚÒ»Á¥ÊôÒ½ÔºÄÔ½ºÖÊÁöҽѧÑо¿ÖÐÐÄ¡¢Éñ¾Íâ¿ÆÀî·É¸±½ÌÊÚ¡¢»ªÖпƼ¼´óѧÎ人¹âµç¹ú¼ÒÑо¿ÖÐÐÄÕÅÖǺì½ÌÊÚÍŶӵÄÆîÊçºì¸±Ñо¿Ô±ÔÚCancer Cell(IF=50.3) Ðû²¼ÎÄÕ¡°Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization¡±¡£½ÒʾÁ˽ºÖÊĸϸ°ûÁöÖÐȱÑõ¾ÞÊÉϸ°ûµÄ±£´æºÍËüÃÇÔÚÖ×ÁöѪ¹ÜÕý³£»¯ÖÎÁÆÖеÄDZÔÚ×÷Óᣠ±¾ÎÄ×÷Õß´ó×ÚÓ¦ÓÃÁËTissue Cytometry¼¼Êõ£¬ÀûÓÿ¹Ìå¶ÔÑù±¾Ö㬶à°Ð±êÂÑ°×½øÐÐÓ«¹â±ê¼Çºó£¬´ÓѪ¹ÜÐÎ̬£¬Ö×Áö¼°Æ仵ËÀÇøÓòʶ±ð£¬È±Ñõ¿Õ¼ä΢Çé¿ö¹æÄ£¹¹½¨²¢Ì½Ë÷΢Çé¿öÖÐϸ°ûºÍѪ¹ÜµÄ×÷ÓùØϵ¡£ ÕâÖÖÔλÊý¾ÝУÑéµÄ˼·£¬²»µ«Ìî²¹ÁËÔλת¼×é¼¼ÊõµÄ¿Õ°×£¬Í¬Ê±½øÒ»²½ÌáÉýÁËÊý¾ÝµÄ¿É¿¿ÐÔ£¬¶ÔÎÄÕ¿´·¨½øÐÐÁËÇ¿ÓÐÁ¦µÄÖ§³Å¡£ ÖÐɽ´óѧÅíËë½ÌÊÚ/Ú÷¶°Ã÷½ÌÊÚÍŶÓÔÚCancer ResearchÉÏÔÚÏßÐû²¼ÌâΪ¡°Crosstalk between myeloid and B cells shapes the distinct microenvironments of primary and secondary liver cancer ¡±µÄÑо¿ÂÛÎÄ¡£ ¸ÃÑо¿Ê״δӵ¥Ï¸°û½Ç¶È¶ÔÔ·¢ÐԺͼ̷¢ÐԸΰ©ÖеÄÃâÒß΢Çé¿ö½øÐÐÁËÉîÈë̽ÌÖ£¬½ÒʾÁ˲î±ðÀàÐ͵Ľ¬Ï¸°ûÓëËèϵϸ°ûÏ໥×÷Óý鵼ÃâÒßÒÖÖÆ΢Çé¿öµÄÏà¹Ø»úÖÆ¡£Ö¤Ã÷ÁËBϸ°ûÊǸÎϸ°û°©( HCC )ºÍ½áÖ±³¦°©¸ÎתÒÆ( CRLM )΢Çé¿öÖеÄÖØÒªµ÷ÀíÒò×Ó¡£ ±¾ÎÄʹÓÃTissueGnostics¹«Ë¾TissueFAXS SpectraÈ«¾°¶à¹âÆ××é֯ɨÃ趨Á¿ÆÊÎöϵͳ¸ÎÔà×éÖ¯Ñù±¾½øÐжàÉ«Ó«¹âͼÏñÊÕÂÞ¡£²¢ÇÒʹÓöàÖØÃâÒßÓ«¹â¼¼Êõ£¬Í¨¹ýAI Classifier¼¼Êõ»ñµÃ´ó×Ú×éÖ¯ÐÎ̬ѧÐÅÏ¢£¬»¹½áºÏÁËTissue Cytometry¼¼ÊõÖо«×¼µÄµ¥Ï¸°ûʶ±ð¼¼Êõ¡£ ͨ¹ý¶àÖÖϸ°ûµÄ×éÖ¯ÔλÐÅÏ¢£¬Ö¤ÊµÁËcxcr3 + Bϸ°ûºÍTAMsͨ¹ýCXCR3-CXCL10ÖáµÄÏ໥×÷Ó㬲¢Í¨¹ý½øÒ»²½ÊµÑ飬·¢Ã÷ÔÚÌåÄÚ×è¶ÏCXCR3¿ÉÒÔÏÔÖøµØ¼õÈõBϸ°ûÏòÖ×ÁöµÄǨÒÆ£¬Ö¤Ã÷ÁËTAMsÔÚHCCÖÐļ¼¯CXCR3 + IgG½¬Ï¸°ûµÄÖØÒª×÷ÓᣠÕã½´óѧÐìæç½ÌÊÚ¡¢Õã´óÒ»¸½ÔºÎÀÇ¿¸±½ÌÊÚµÈÍŶÓÔÚCellular and Molecular BiologyÐû²¼ÌâΪ¡°Downregulation of N4-acetylcytidine modification in myeloid cells attenuates immunotherapy and exacerbates hepatocellular carcinoma progression¡±µÄÎÄÕ¡£Í¨¹ý¼ì²â HCC ÃâÒßÖÎÁÆÆÚ¼äÖÖÖÖÃâÒßϸ°ûÑÇȺÖÐ ac4C ˮƽµÄ±ä¸ï£¬ÑéÖ¤ÁËac4CÐÞÊÎÔÚHCCÃâÒßÖÎÁÆÖеÄÖØÒª×÷Óᣠ×÷Õß½èÖúTissueCytometry¼¼Êõ£¬¾«È·Á¿»¯Ï¸°ûÃܶȺÍÂÑ°×±í´ïˮƽ£¬ÎªÑо¿ÕßÌṩÁ˹ØÓÚÖ×Áö΢Çé¿öÖÐϸ°ûÂþÑܺÍ״̬µÄÏêϸÐÅÏ¢¡£Í¨¹ý¶Ô¸Îϸ°û°©ÖÐac4C+CD11b+ϸ°ûÂþÑÜÃܶȵĶ¨Á¿£¬ÆÊÎöÁËac4C+CD11b+ϸ°û±ÈÀýÓëHCC»¼ÕßÔ¤ºóÖ®¼äµÄ¹Øϵ£¬·¢Ã÷¸ß½þÈóµÄac4C+CD11b+ϸ°ûÓë¸üºÃµÄÔ¤ºóÕýÏà¹Ø¡£